Point of Care Diagnostics

Point of Care Diagnostic tests are projected to represent a market of $15 billion by 2010, and have experienced growth rates of around 10% per year. Their increasing implementation into clinical practice is changing the way that physicians operate, and new technological developments are opening up opportunities for those who commercialise POCT.

SMi’s conference on Point of Care Diagnostics will present a leading array of experts in this exciting field of healthcare technology. Presentations will address the following areas:

• Market access, regulation and pricing and reimbursement for point of care diagnostics in the major markets of Europe, the US and the developing world.
• Updates on the latest technology platforms – case studies from diagnostics providers will reveal the latest advances in diagnostic testing
• The prospects for using PoC in the development of personalised medicine
• How changing clinical practice is being affected by the implementation of point of care testing 

Our line-up of top speakers so far includes:

• David Huckle, Chief Executive, Adam’s Business Associates
• Neil Butler, CEO, Vicacta
• Anil Modak, Associate Director, Medical Products Research and Development, Cambridge Isotope Laboratories
• Gert Blankenstein, Head of Product Development, Boehringer Ingelheim microParts GmbH
• Chris Price, Professor, University of Oxford
• Mark Charny, Managing Director, Translucency *
• Nanette Kerr, Head of Professional Services Development, Boots UK
• Jon Cooper, Professor of Bioelectronics and Bioengineering, University of Glasgow
• Mark O’Connell, Director, Probe Scientific
• Representative of Frost and Sullivan
• Gilbert Wieringa, Consultant Clinical Scientist, Greater Manchester PCT
• Christina Rode-Schubert, Secretary General, Connectivity Industry Consortium Europe
• Thomas Norgall, Fraunhofer-Institut für Integrierte Schaltunge.n Erlangen
• Richard Taylor, Consultant Clinical Scientist, John Radcliffe Hospital
• Steven Wong, Professor of Pathology & Scientific Director, Toxicology Department, Milwaukee County Examiners Office, Medical University of Wisonsin
• Robert Jenkins, Corporate Business Development Manager, Biokit SA
• Ciara O'Sullivan, Professor of Chemical Engineering, Universitat Rovira i Virgili

This event is targeted at those involved in developing, marketing and using point of care diagnostics, including the following job titles:

• CSOs
• CTOs
• Directors/Heads/VPs of Diagnostic Research and Development
• Directors/Heads/VPs of Business Development
• Directors/Heads/VPs of Point of Care
• Hospital CEOs, CIOs, CFOs
• Physicians
• Pharmacists
• Pathologists
• Clinical Scientists
• Policy Makers

Previous years attendees have included representatives of the following companies:

• Abbott Point of Care
• Genzyme Diagnostics Ltd
• Roche Diagnostics Ltd
• ALK-Abello A/S
• Biokit S.A
• Nanogen
• Irish Medicines Board
• Diasys Diagnostic Systems
• Institute of Biomedical Science
• Securetec Detektions-Systeme AG
• Health Protection Agency
• Cytyc Development & Corporation
• Orion Diagnostica Phadia AB
• DiagnOx
• Capio Diagnostics UK
• Department of Health
• Radiometer Medical APS
• Connector
• Meretek Diagnostics Inc
• Tyco Healthcare Group L P
• Nolato Medical
• BioMerieux
• Medifiq
• Orion Corporation
• Noiro
• BIOSURFIT
• Horiba ABX
• Perlos Corporation
• Laboratorios Leti S.L  
• TriVirix
• Johnson & Johnson/McNeil Consumer Healthcare